Insider · CIK 0001296027

deBethizy J Donald

Reports to the SEC for 1 company · WINSTON-SALEM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001296027

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2012-05-04	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+135K sh	—	—	135,000
2012-02-14	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+798 sh	$5.10	+$4,069.8	798
2012-02-14	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−798 sh	—	—	0
2011-03-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+105K sh	—	—	105,000
2010-01-19	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+70K sh	—	—	70,000
2009-12-16	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+6,769 sh	$3.52	+$23.9K	35,695
2009-12-16	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+202K sh	$1.75	+$354K	237,930
2009-12-16	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−28.3K sh	$22.00	−$623K	209,634
2009-12-16	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−630 sh	$22.99	−$14.5K	209,004
2009-12-16	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−209K sh	$21.98	−$4.59M	0
2009-12-16	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−6,769 sh	—	—	0
2009-12-16	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,187 sh	—	—	8,751
2009-12-16	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−75.6K sh	—	—	28,211
2009-12-16	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−124K sh	—	—	0
2009-12-15	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−15.4K sh	$22.28	−$343K	28,926
2009-12-14	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−2,600 sh	$22.44	−$58.3K	44,317
2009-09-08	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+851 sh	$1.75	+$1,489.25	47,768
2009-09-08	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−851 sh	$15.00	−$12.8K	46,917
2009-09-08	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−851 sh	—	—	124,403
2009-09-04	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.1K sh	$1.75	+$19.5K	58,066
2009-09-04	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−11.1K sh	$15.02	−$167K	46,917
2009-09-04	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−11.1K sh	—	—	125,254
2009-08-31	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+9,400 sh	$1.75	+$16.5K	56,317
2009-08-31	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−9,400 sh	$14.54	−$137K	46,917
2009-08-31	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−9,400 sh	—	—	136,403
2009-08-28	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+600 sh	$1.75	+$1,050	47,517
2009-08-28	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−600 sh	$14.50	−$8,700	46,917
2009-08-28	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−600 sh	—	—	145,803
2009-08-24	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,400 sh	$1.75	+$4,200	49,317
2009-08-24	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−2,400 sh	$13.52	−$32.4K	46,917
2009-08-24	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,400 sh	—	—	146,403
2009-08-14	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+4,600 sh	$1.75	+$8,050	51,517
2009-08-14	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−4,600 sh	$13.51	−$62.1K	46,917
2009-08-14	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−4,600 sh	—	—	148,803
2009-08-07	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,700 sh	$1.75	+$9,975	52,617
2009-08-07	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−2,850 sh	$12.02	−$34.3K	49,767
2009-08-07	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−2,850 sh	$12.04	−$34.3K	46,917
2009-08-07	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,700 sh	—	—	153,403
2009-07-29	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,700 sh	$1.75	+$9,975	52,617
2009-07-29	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−4,400 sh	$11.05	−$48.6K	48,217
2009-07-29	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−1,300 sh	$12.00	−$15.6K	46,917
2009-07-29	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,700 sh	—	—	159,103
2009-07-28	GYREGYRE THERAPEUTICS, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+2,600 sh	$1.75	+$4,550	49,517
2009-07-28	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President and CEO	SSale	−2,600 sh	$11.01	−$28.6K	46,917
2009-07-28	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−2,600 sh	—	—	164,803
2009-01-09	GYREGYRE THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+65K sh	—	—	65,000

Recent filings

Accepted (ET)
May 84
deBethizy J Donald0001140361-12-023732
SEC(opens sec.gov)
Feb 164
deBethizy J Donald0001140361-12-009137
SEC(opens sec.gov)
Mar 314
deBethizy J Donald0001140361-11-019845
SEC(opens sec.gov)
Jan 214
deBethizy J Donald0001140361-10-002237
SEC(opens sec.gov)
Dec 184
deBethizy J Donald0001140361-09-029749
SEC(opens sec.gov)
Dec 164
deBethizy J Donald0001140361-09-029416
SEC(opens sec.gov)
Sep 94
deBethizy J Donald0001140361-09-020514
SEC(opens sec.gov)

Companies

GYRE THERAPEUTICS, INC.Director, President and CEOGYRE

Address

C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101